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In a recent Viewpoint article in The Journal of the American
Medical Association, ArjunManrai, John Ioannidis, and Isaac
Kohane argue that before we further cement the five-cate-
gory classification scale for variant interpretation (benign
to pathogenic), we should rethink what would bemost use-
ful for patients and physicians. The authors argue strongly
that variants should be assigned a more quantitative mea-
sure of risk to patients rather than be classified as either
‘‘good’’ or ‘‘bad.’’ To do this, they propose a shared informa-
tion commons of genetic data. Although ClinGen has been
a resource designed for information sharing to foster agree-
ment in variant classification between labs, Manrai et al.
would like to see a resource that goes further by providing
a way to share granular phenotype and genotype data that
will allow derivation of these variant-specific risk estimates.
Manrai et al. (2016). JAMA 315, 1233–1234.Human Knockouts
Homozygous loss-of-function variation has been reported
in recent population studies. Although it seems puzzling
that the complete absence of function of a certain gene
would be found in a group of supposedly healthy individ-
uals, many of these genotypes are actually composed of
common, benign alleles. To identify variation that might
be more clinically relevant, Narasimhan et al. focused on
rare homozygous loss-of-function variation (rhLOF) in a
population study, and to stack their chance of finding
these individuals, they started with a consanguineous pop-
ulation. In their sample of about 3,000 people, 821 had at
least one rhLOF variant, and 54 of these were in recessive
OMIM genes, despite the fact that the individuals in the
sample were ascertained as being adults who were healthy,
pregnant, or type 2 diabetic. On further analysis, some of
the variants were false positives, but health records indi-
cated that six individuals had a diagnosis consistent with
the rhLOF variant they carried. This left a group of appar-
ently unaffected individuals with a putative disease geno-
type, an idea supported by the fact that the rhLOF group
did not exhibit an increased rate of receiving prescription
medications or consulting with a healthcare professional.
These data suggest that as we use large population datasets
in variant interpretation, we must be cautious in our
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sequencing for predictive purposes, we must apply our in-
terpretations with caution.
Narasimhan et al. (2016). Science. Published online March
3, 2016. http://dx.doi.org/10.1126/science.aac8624.Selfish Mutations in Men
Althoughperhapsnot aswell knownas thematernal-age ef-
fect for aneuploidy, paternal age is associatedwith increased
risk of de novo dominant disorders in children. This risk
partly goes back to the number of times the DNA has been
replicated during spermatogenesis, but some have sug-
gested that, beyond this, there is selection for spermato-
gonia that have certain ‘‘selfish’’ mutations. Maher et al.
used laser dissectionof testicular tissue tofindevidence sup-
porting this idea. In the testes from multiple men, they
found gain-of-function mutations in components of the
EGFR-RAS signalingpathway.Constitutionally, thesemuta-
tions would cause disorders such as Crouzon syndrome or
thanatophoric dysplasia, but in the testes, they lead to
clonal expansion because of a selective advantage.
Maher et al. (2016). Proc. Natl. Acad. Sci. USA 113, 2454–
2459.Parental Dependence to RB Penetrance
Although mutations in RB1 generally exhibit autosomal-
dominant inheritance with nearly complete penetrance of
retinoblastoma, a childhood tumor of the eye, some RB1
variants, particularly the relatively common c.1981C>T
(p.Arg661Trp), have reduced penetrance. Confusingly,
this seems not to be the case in some families, who exhibit
high penetrance of the same variant. Eloy et al. compiled a
large set of families with c.1981C>T (p.Arg661Trp) and
other RB1 variants with reduced penetrance and discov-
ered a parent-of-origin effect on the penetrance. When in-
herited from mothers, these variants have much lower
penetrance (10%) than when they are inherited from
fathers (68%). This seems to be governed by parent-of-
origin-specific methylation of a CpG island that is located
in intron 2 of RB1 and fosters higher expression from the
maternal allele. Although higher production of themutant
allele might seem like a bad thing, when you employ the
two-hit hypothesis, it makes sense. The second hit would
eliminate function of the wild-type RB1 allele, leavingta, GA 30322, USA
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only the mutant. If the pathogenic variant reduces but
doesn’t wipe out RB function, the maternal boost to the
protein level might exceed the amount necessary for tu-
mor suppression. In contrast, the lower expression of the
paternal allele does not cross this threshold of activity.
Highly penetrant RB1 variants have very low or null activ-
ity and don’t have sufficient tumor-suppressor activity
even with the maternal boost in expression.
Eloy et al. (2016). PLOS Genet. 12, e1005888.Recurrent Breaks in Genes Involved in Neural
Function
Cells of the immune system are a paradigm for genomic
rearrangements during their maturation process. A recent596 The American Journal of Human Genetics 98, 595–596, April 7, 2study hints that high rates of DNA breaks and rearrange-
ments might also occur in neuronal cells. Fred Alt’s group
took an unbiased approach to identifying 27 genomic re-
gions that have recurrent double-strand breaks in neural
stem and progenitor cells. The sites of recurrent breaks
are all within gene bodies, and the majority of these genes
are longer than 100 kb and have roles in neural cell
adhesion or synaptic function. Indeed, most of them
have also been linked to neurodevelopmental or neuro-
psychiatric disorders. What role does this DNA breakage
have in neurons? We don’t yet know, but in an accompa-
nying Preview article, Irving Weissman and Fred Gage
speculate that this might foster neuronal diversification
and be necessary for the development of individual
identity.
Wei et al. (2016). Cell 164, 644–655.This Month in Our Sister JournalsThe Hidden Genome
Now that thousands of genomes have been sequenced, we
have a much better understanding of genetic variation at
the single-nucleotide level. Next-generation sequencing
techniques have much lower sensitivity for other types
of variation, and in a recent Commentary, John Hud-
dleston and Evan Eichler discuss this hidden part of
the genome. They summarize how much of the struc-tural variation and insertion-deletion variation we are
likely to be missing, and they offer short-term steps
to rectify this shortcoming. These solutions include
sequencing population samples to a higher depth and
making the data publicly available, as well as using addi-
tional sequencing technologies to characterize the same
samples.
Huddleston and Eichler (2016). Genetics. http://dx.doi.org/
10.1534/genetics.115.180539.016
